ATAI ATAI Life Sciences BV
Company Analysis
Latest News
🟢 ATAI Life Sciences is trading 32% up today as FDA finalizes psychedelic drug development guidance
ATAI Life Sciences is trading 32% higher at $7.08 after the FDA finalized new guidance for psychedelic drug development, reducing regulatory uncertainty for...
ATAI Life Sciences Gains, FDA Finalizes New Psychedelic Drug Guidance
ATAI Life Sciences and the psychedelic drug sector received a boost following finalized FDA guidance. This regulatory shift aims to reduce uncertainty and risk...
Eli Lilly to Acquire AtaiBeckley for $6.75 Per Share Plus Contingent Payments
AtaiBeckley Inc. (ATAI) has entered into a definitive merger agreement to be acquired by Eli Lilly and Company. Under the terms of the agreement, AtaiBeckley...
🟢 ATAI Life Sciences is trading 45.1% up today on reports of Eli Lilly's potential acquisition of AtaiBeckley
ATAI Life Sciences is trading 45.1% up today at $7.79 following reports that Eli Lilly is in advanced talks to acquire AtaiBeckley, a psychedelic drug...
🟢 ATAI Life Sciences is trading 45.1% up today on reports of Eli Lilly takeover talks for AtaiBeckley
ATAI Life Sciences is trading 45.1% up today at $7.78 following reports that Eli Lilly is in advanced talks to acquire AtaiBeckley, a psychedelic drug...
🟢 ATAI Life Sciences is trading 10.1% up
ATAI Life Sciences is trading at $5.47, up 10.1% from a comparison close of $4.97 during regular trading. This is a price-action follow-up, so a separate...
🟢 ATAI Life Sciences is trading 5.7% up today as Canaccord Genuity raises price target to $17
ATAI Life Sciences is trading 5.7% up at $5.25 following a price-target increase from Canaccord Genuity and continued optimism surrounding its...
🔴 ATAI Life Sciences is trading 5% down today on profit-taking after recent rally
ATAI Life Sciences is trading 5% down at $4.91 today, giving back a portion of its recent gains following a period of significant outperformance. • The...
🟢 ATAI Life Sciences is trading 5.2% up today on renewed takeover speculation and BPL-003 trial success
ATAI Life Sciences is trading at $5.44 (+5.21%) amid renewed takeover speculation and continued enthusiasm for its psychedelic drug pipeline. • The company is...
ATAI Life Sciences draws US pharma takeover interest, following trial milestone
ATAI Life Sciences is reportedly attracting takeover interest from a major U.S. pharmaceutical company. A Betaville alert referenced by traders on July 6,...
🟢 ATAI is trading 5.2% up today after dosing final patient in Phase 2b depression trial
ATAI is trading 5.2% up at $5.22 after announcing it has dosed the last patient in its Phase 2b Elumina trial of VLS-01 for treatment-resistant depression. •...
ATAI Life Sciences Completes DMT Depression Trial Dosing, Eyes 2026 Data
ATAI Life Sciences subsidiary AtaiBeckley has dosed the final patient in its Phase 2b Elumina clinical trial. The study evaluates VLS-01 for the treatment of...
🟢 ATAI makes sharp 10.3% jump
ATAI is trading at $5.05, up 10.3% versus the comparison close of $4.58 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ATAI surges 10% today, extending rally on Russell Index inclusion news
ATAI is trading approximately 10% up at $5.04, extending a sharp multi-day rally. • The stock continues to benefit from the announcement on June 25, 2026,...
🔴 ATAI is trading 5.9% down today in a consolidation move after yesterday's sharp gains
ATAI is trading at $4.31 (5.9% down) in pre-market as the stock consolidates following yesterday's sharp gains and a multi-day rally. • The pullback follows a...
🟢 ATAI makes sharp 10.2% jump
ATAI is trading at $4.59, up 10.2% versus the comparison close of $4.17 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ATAI Surges 6.1% Today on Russell Index Inclusion and Strong Micron Earnings
• ATAI stock is trading up 6.12% at $4.42 today. • The company announced its inclusion in the Russell 2000® and Russell 3000® Indexes, effective June 29, 2026,...
🟢 ATAI Life Sciences BV makes sharp 11.4% jump
ATAI is trading at $4.28, up 11.4% versus the comparison close of $3.84 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 ATAI Life Sciences BV is trading 6.1% up today as analysts maintain a Strong Buy consensus
ATAI Life Sciences BV is trading 6.1% up today at $4.08, extending a recent rebound from the high-$3 range as Wall Street analysts maintain a bullish...